Why the study?
The study aimed to evaluate endothelial dysfunction via flow mediated dilation in patients with severe CAD scheduled for CABG, and examine its association with coronary, carotid, and peripheral atherosclerosis.
Does flow-mediated dilation (FMD) correlate with the severity of coronary, carotid, and peripheral atherosclerosis in patients with severe CAD scheduled for CABG?
Does flow-mediated dilation (FMD) correlate with the severity of coronary, carotid, and peripheral atherosclerosis in patients with severe CAD scheduled for CABG?
Flow-mediated dilation is a reliable non-invasive surrogate marker that strongly correlates with systemic atherosclerotic burden, including coronary, carotid, and peripheral artery disease severity, in high-risk patients requiring CABG.
FMD may mark multi-bed atherosclerosis severity in CABG candidates; hypothesis-generating and requires prospective validation before clinical use.
Purpose: The study aimed to evaluate endothelial dysfunction (ED), assessed through flow mediated dilation (FMD), in individuals with severe coronary artery disease (CAD) scheduled for coronary artery bypass graft surgery (CABG). Additionally, we examined the association between the severity of EDevaluated throughFMD and the extent of atherosclerosis at the coronary arteries level (SYNTAX I score), carotid arteries and peripheral arteries. Methods: The study included 84 participants recruited between January 2020 and June 2021. Doppler ultrasonography was used to assess both FMD and the degree of carotid artery stenosis. SYNTAX I score was calculated based on coronary angiography, and peripheral artery disease (PAD) was evaluated using computed tomography. Results: FMD was used as a surrogate for assessing ED. We found no statistical difference between men and women [4.46 (1.03– 6.75) in women versus 2.55 (0.95– 6.13 in men; p=0.21). A significant association was observed between FMD and SYNTAX score (p < 0.001). A lower FMD corresponded to a higher SYNTAX score, reflecting an extensive burden of coronary atherosclerosis. Furthermore, ED, as measured by FMD, was indicative of carotid atherosclerosis and PAD, as evidenced by lower FMD in patients with severe carotid plaques (p < 0.001) and severe PAD (p < 0.01). Conclusion: FMD might be a reliable tool to assess systemic atherosclerosis, ED in the brachial artery being related to carotid artery plaque, CAD and peripheral lower limb ischemia.
No takes yet. Share an insight, caveat, or question.
Boieriu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: